JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

Search

Accuray Inc

Fechado

SetorSaúde

0.45 2.27

Visão Geral

Variação de preço das ações

24h

Atual

Mín

0.45

Máximo

0.46

Indicadores-chave

By Trading Economics

Rendimento

7.9M

-14M

Vendas

8.3M

102M

EPS

-0.108

Margem de lucro

-13.468

Funcionários

990

EBITDA

7M

-3.3M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+334.78% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-36M

55M

Abertura anterior

-1.82

Fecho anterior

0.45

Sentimento de Notícias

By Acuity

100%

0%

339 / 348 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Accuray Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de abr. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26 de abr. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Major Central Bank -2-

24 de abr. de 2026, 19:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek Group Rejects EQT's Revised Offer

26 de abr. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26 de abr. de 2026, 23:44 UTC

Ganhos

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26 de abr. de 2026, 23:44 UTC

Ganhos

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26 de abr. de 2026, 23:36 UTC

Conversa de Mercado
Notícias Principais

Gold Falls Amid Dollar's Strength -- Market Talk

26 de abr. de 2026, 23:33 UTC

Conversa de Mercado
Notícias Principais

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26 de abr. de 2026, 05:12 UTC

Ganhos

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24 de abr. de 2026, 23:37 UTC

Aquisições, Fusões, Aquisições de Empresas

Scoring the Cook Era -- Barrons.com

24 de abr. de 2026, 20:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Financial Services Roundup: Market Talk

24 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

24 de abr. de 2026, 20:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 20:09 UTC

Ganhos

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 de abr. de 2026, 19:48 UTC

Conversa de Mercado
Notícias Principais

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 de abr. de 2026, 19:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 de abr. de 2026, 19:25 UTC

Aquisições, Fusões, Aquisições de Empresas

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 de abr. de 2026, 19:22 UTC

Ganhos

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 de abr. de 2026, 19:06 UTC

Ganhos

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 de abr. de 2026, 19:05 UTC

Conversa de Mercado

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 de abr. de 2026, 18:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 de abr. de 2026, 18:28 UTC

Aquisições, Fusões, Aquisições de Empresas

Intertek Rejects Revised EQT Offer

24 de abr. de 2026, 18:12 UTC

Conversa de Mercado

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 de abr. de 2026, 18:06 UTC

Conversa de Mercado

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 de abr. de 2026, 17:42 UTC

Ganhos

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 de abr. de 2026, 17:28 UTC

Ganhos

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Comparação entre Pares

Variação de preço

Accuray Inc Previsão

Preço-alvo

By TipRanks

334.78% parte superior

Previsão para 12 meses

Média 2 USD  334.78%

Máximo 2 USD

Mínimo 2 USD

Com base em 1 analistas de Wall Street que oferecem metas de preço de 12 meses para Accuray Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

1 ratings

1

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

1.28 / 1.61Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

339 / 348 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
help-icon Live chat